Automobile and Automotive

Global Rheumatoid Arthritis Pharmacotherapeutics Market

Written by Gaarti

 

The Global Rheumatoid Arthritis Pharmacotherapeutics Market is expected to reach $xx Mn in 2027 from $xx Mn in 2019, at a CAGR of xx% during the forecast period.

 

Rheumatoid Arthritis is a chronic autoimmune disease marked by systemic inflammation, which affects not only joints but a wide range of extra-articular organs. If not treated early may lead to progressive joint deformity & increased morbidity and mortality. Some classic examples of joint deformities associated with RA are Boutonniere deformity visible in the 5th digit of the right hand, Swan neck deformity in the 5th digit of the left hand and Hallux Valgus can be seen in the foot.

 

Nearly 5% of women and 3% of men over the age of 65 years are affected by this. Combination therapies are being used to treat rheumatoid arthritis.

 

Market overview:

 

Increasing investments in the field of R&D of drugs is contributing to the growth of the market. Along with this, the rising geriatric population also drives the market upwards. Cigarette smoking is a strong risk factor that leads to substantial growth in Rheumatoid Arthritis market. The presence of high-cost drugs and favorable reimbursement policies are the most prominent driving factors for the growth of the market. The anti –TNF factors are used as first-line treatment for RA, but owing to the launch of new biologics in the global market is likely to hamper the demand for TNF inhibitors.

 

Regional insights:

 

Global Rheumatoid Arthritis Pharmacotherapeutics Market

 

North America dominates the global market owing to the remarkable healthcare infrastructure in the country. According to the regional analysis done, affordable health care across North America is expected to boost the market. Increasing awareness and healthcare expenditure are likely to improve the demand for rheumatoid arthritis Pharmacotherapeutics market during the forecast period. Following North America, Asia Pacific is expected to hold the second-largest share in the global market due to the growing number of unmet medical needs and increasing geriatric population.

 

Market segmentation:

By Drug-Class:

 

  • Non-steroidal anti-inflammatories (NSAIDs)
  • Disease Modifying Anti-Rheumatic Drugs (DMARDs)

 Methotrexate (MTX)

 Hydroxychloroquine (HCQ)

 Sulfasalazine (SSZ)

  • Corticosteroids
  • Analgesics
  • Anti- Tumor Necrosis Factor (anti-TNF)

By Route of Administration:

 

  • Oral
  • Subcutaneous
  • Intravenous

 

Segment Analysis:

 

Global Rheumatoid Arthritis Pharmacotherapeutics Market1

 

Currently, anti-TNF is the most prominently growing segment, which is used as a first-line biologic treatment worldwide. Various anti-TNFs like Remicade, Humira, and Enbrel are prescribed for the first line of treatment.

Key players operating in the Global Rheumatoid Arthritis Pharmacotherapeutics Market:

 

  • Amgen
  • Johnson & Johnson
  • Abbott
  • Abbvie Inc.
  • Pfizer Inc.
  • Celgene corporation
  • Bristol-Myers Squibb Company
  • Hoffman-La Roche Ltd.
  • UCB S.A.
  • Eli Lilly and Company
  • Gilead Sciences Inc.
  • Takeda Biosciences
  • Merck
  • Taisho Pharmaceuticals
  • Viela Bio

 

Competitive Landscape:

 

According to the news released in March 2020, Roche announced the conduction of Phase III trial of Actemra in collaboration with US Food and Drug Administration (FDA).

 

The objective of the report is to present a comprehensive analysis of the Global Rheumatoid Arthritis Pharmacotherapeutics Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

 

The report also helps in understanding Global Rheumatoid Arthritis Pharmacotherapeutics Market dynamics, structure by analyzing the market segments and project the Global Rheumatoid Arthritis Pharmacotherapeutics Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Rheumatoid Arthritis Pharmacotherapeutics Market make the report investor’s guide.

 

For More Information Vist: https://www.maximizemarketresearch.com/market-report/global-rheumatoid-arthritis-pharmacotherapeutics-market/81530/

Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

 

This Report Is Submitted By : Maximize Market Research Company

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.

Contact: +919607195908     8989132284

 

 

 

 

 

 

 

About the author

Gaarti

Leave a Comment